| Title : A phase 1, safety, tolerability, and pharmacokinetics study of bisnorcymserine, a highly selective inhibitor of butyrylcholinesterase - Tzieras_2026_Neurotherapeutics_23_e00918 |
| Author(s) : Tzieras I , Manolopoulos A , Tweedie D , Luo W , Maccecchini M , Egan JM , Greig NH , Kapogiannis D |
| Ref : Neurotherapeutics , 23 :e00918 , 2026 |
| Abstract : |
| PubMedSearch : Tzieras_2026_Neurotherapeutics_23_e00918 |
| PubMedID: 42127455 |
| Gene_locus related to this paper: human-BCHE |
| Title : Immunoglobulin for myasthenia gravis - Manolopoulos_2025_Cochrane.Database.Syst.Rev_10_Cd013801 |
| Author(s) : Manolopoulos A , Alzuabi M , Elmashala A , Cashwell J , Murad MH , Naddaf E |
| Ref : Cochrane Database Syst Rev , 10 :Cd013801 , 2025 |
| Abstract : |
| PubMedSearch : Manolopoulos_2025_Cochrane.Database.Syst.Rev_10_Cd013801 |
| PubMedID: 41090479 |